The World Health Organisation on Wednesday said it expects to receive clarifications from Bharat Biotech by the end of this week on its COVID-19 vaccine — Covaxin — and will…
A technical advisory group of the World Health Organisation was on Tuesday reviewing data on Covaxin for the emergency use listing of India’s indigenously-made vaccine and it could pronounce its…
New Delhi: Appreciating the efforts made by the leading vaccine manufacturers of the country which helped in achieving the milestone of 100 crore COVID-19 vaccinations in the country, Prime Minister…
NEW DELHI: Chairman and Managing Director of Bharat Biotech, Dr. Krishna Ella on Saturday said that they are waiting for approval from the Drugs Controller General of India (DCGI) for…
As a decision is awaited on the Emergency Use Listing of Covaxin being manufactured in India, a top WHO official has said the process of thoroughly evaluating a vaccine for…
United Nations/Geneva: The World Health Organisation on Monday said it was expecting additional information from India’s Bharat Biotech regarding its COVID-19 jab Covaxin, asserting that it “cannot cut corners” before…
Hyderabad-based Bharat Biotech, the manufacturer of indigenous Covid-19 vaccine Covaxin, is aiming to produce 70-80 million doses monthly from December, lagging way behind the government’s 400 million production estimate between…
KOCHI: Inactivated vaccine like Covaxin has failed to generate humoral immune response or antibody-mediated immunity in more than 50% of the patients on immunosuppressants, thereby exposing them to higher risk…
The Strategic Advisory Group of Experts on Immunization (SAGE) of the World health Organisation (WHO) will meet on Tuesday to make its recommendations on Bharat Biotech’s Covid-19 vaccine Covaxin on…
The WHO will take a decision on Bharat Biotech’s Covaxin for granting Emergency Use Listing (EUL) in October. While the rolling review started in July, the WHO document on the…
